<?xml version="1.0" ?>
<document id="069bf4da8f0f4f540b9f6a16021e007442e7e027">
  <chunk id="069bf4da8f0f4f540b9f6a16021e007442e7e027.c0" text="MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2"/>
  <chunk id="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1" text="Humoral immune responses initiate in the lymph node draining the site of viral infection (dLN). Some viruses subvert LN B cell activation; however, our knowledge of viral hindrance of B cell responses of important human pathogens is lacking. Here, we define mechanisms whereby chikungunya virus (CHIKV), a mosquito-transmitted RNA virus that causes outbreaks of acute and chronic arthritis in humans, hinders dLN antiviral B cell responses. Infection of WT mice with pathogenic, but not acutely cleared CHIKV, induced MyD88dependent recruitment of monocytes and neutrophils to the dLN. Blocking this influx improved lymphocyte accumulation, dLN organization, and CHIKV-specific B cell responses. Both inducible nitric oxide synthase (iNOS) and the phagocyte NADPH oxidase (Nox2) contributed to impaired dLN organization and function. Infiltrating monocytes expressed iNOS through a local IRF5-and IFNAR1-dependent pathway that was partially TLR7-dependent. Together, our data suggest that pathogenic CHIKV triggers the influx and activation of monocytes and neutrophils in the dLN that impairs virus-specific B cell responses.">
    <entity charOffset="327-330" id="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e0" ontology_id="CHEBI_33697" text="RNA" type="chemical"/>
    <entity charOffset="413-422" id="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e1" ontology_id="CHEBI_22587" text="antiviral" type="chemical"/>
    <entity charOffset="711-723" id="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e2" ontology_id="CHEBI_16480" text="nitric oxide" type="chemical"/>
    <entity charOffset="718-723" id="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e3" ontology_id="CHEBI_25741" text="oxide" type="chemical"/>
    <entity charOffset="758-763" id="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e4" ontology_id="CHEBI_16474" text="NADPH" type="chemical"/>
    <entity charOffset="914-921" id="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e5" ontology_id="CHEBI_34922" text="pathway" type="chemical"/>
    <pair e1="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e0" e2="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e1" id="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.p0" relation="true"/>
    <pair e1="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e0" e2="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e2" id="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.p1" relation="true"/>
    <pair e1="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e0" e2="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e3" id="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.p2" relation="true"/>
    <pair e1="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e0" e2="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e4" id="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.p3" relation="true"/>
    <pair e1="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e0" e2="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e5" id="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.p4" relation="true"/>
    <pair e1="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e1" e2="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e2" id="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.p5" relation="true"/>
    <pair e1="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e1" e2="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e3" id="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.p6" relation="true"/>
    <pair e1="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e1" e2="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e4" id="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.p7" relation="true"/>
    <pair e1="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e1" e2="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e5" id="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.p8" relation="true"/>
    <pair e1="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e2" e2="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e3" id="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.p9" relation="true"/>
    <pair e1="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e2" e2="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e4" id="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.p10" relation="true"/>
    <pair e1="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e2" e2="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e5" id="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.p11" relation="true"/>
    <pair e1="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e3" e2="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e4" id="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.p12" relation="true"/>
    <pair e1="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e3" e2="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e5" id="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.p13" relation="true"/>
    <pair e1="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e4" e2="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.e5" id="069bf4da8f0f4f540b9f6a16021e007442e7e027.c1.p14" relation="true"/>
  </chunk>
  <chunk id="069bf4da8f0f4f540b9f6a16021e007442e7e027.c2" text="Elucidating mechanisms by which viruses subvert B cell immunity and establish persistent infection is essential for the development of new therapeutic strategies against chronic viral infections. The humoral immune response initiates in the lymph node draining the site of viral infection. However, how persistent viruses evade B cell responses is poorly PLOS Pathogens | https://doi."/>
</document>
